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ABSTRACT
Drug rash with eosinophilia and systemic symptoms (DRESS) syndrome, is a type of hypersensitivity reaction, mainly due to antiepileptic drugs. 
Lamotrigine is a newer broad-spectrum antiepileptic that can be used in both children and adults. Lamotrigine-induced DRESS syndrome is a rare 
case with incidence of 1/1000 to 1/10000. This syndrome manifests as rash, fever, tender lymphadenopathies, hepatitis, and eosinophilia. This case 
highlights the need for early diagnosis and treatment of such a rare and life-threatening event because early detection of the condition leads to early 
recovery of the patient. Further re-exposure to the drug should be avoided.
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INTRODUCTION
Drug reaction with eosinophilia and systemic symptoms (DRESS) 
syndrome, a type of hypersensitivity reaction, is a severe idiosyncratic 
reaction to drugs. Many drugs are implicated in causing DRESS which 
includes antiepileptics, and dapsone. Lamotrigine is a broad spectrum 
newer antiepileptic used for both children and adults. Common 
side effects include dizziness, ataxia, and diplopia but lesser known 
side effect is DRESS syndrome with incidence 1/1000 to 1/10000 
exposures [1]. Here, we report a case of lamotrigine-induced DRESS 
syndrome.
CASE REPORT
Informed consent was taken from the patient. A 22-year-old female 
came with complaints of itchy red lesions all over the body for 5 days and 
fever for 1 week. The patient was a known case of epilepsy for 8 years 
and was on tablet levetiracetam for 1 year. The patient was started on 
lamotrigine 1 month back along with levetiracetam. Fever was a mild 
grade in nature and rashes had started locally a week back and became 
widespread all over the body and hand after 3 days. Skin examination 
revealed focal and erythematous macular rash on face, trunk, and 
upper hands. No other systemic complaints were noticed. Vitals were 
stable, and another system examination was normal. Laboratory 
investigations revealed elevated liver enzymes with elevated eosinophil 
count and erythrocyte sedimentation rate (Table 1). Other laboratory 
investigations were normal. The drug lamotrigine was stopped, and 
patient was treated with derma dew lotion local application 1-0-0, 
saran lotion for local application 1-0-0, paracetamol 650 mg, tablet 
levocetirizine 5 mg 0-0-1 then changed to zyrtec 10 mg 0-0-1, tablet 
atarax 25 mg 0-0-1, syrup zincovit 0-0-1 2 tsp, lactihusk powder 0-0-1 
sos, tab levipil 750 m 1-0-1, and injection avil 2 cc im sos. Treatment 
was continued for 4 days and epilepsy only levetiracetam was given. 
The patient showed improvement in condition and was discharged on 
the 5th day with medications and was asked to review after 1 month or 
earlier if any symptoms reappear.
DISCUSSION
DRESS syndrome is caused by drugs such as phenobarbital, phenytoin, 
lamotrigine, carbamazepine, minocycline, and dapsone. Furthermore, 
may be caused by human herpes virus-8. Cases of DRESS syndrome 
have been reported with clinical features appearing 3-4 weeks after the 
administration of lamotrigine. This corresponds to the latency period 
commonly reported in the literature. The interval between first drug 
exposure and symptoms is usually 2-4 weeks but has been reported 
in individuals receiving anticonvulsants for 3 months [2]. Incidence 
of DRESS syndrome is estimated to be 1/1,000-1/10,000 exposures. 
Lamotrigine-induced DRESS syndrome is very rare. This syndrome 
manifests as rash, fever, tender lymphadenopathies, hepatitis, and 
eosinophilia. DRESS syndrome is a potentially life-threatening 
multisystem adverse drug reaction, and accidental re-exposure and 
drug provocation tests must be avoided. Patients, their relatives, and 
treating physicians must be well informed about the causal drug. The 
incidence of DRESS syndrome is higher among first-degree relatives, 
it often mimics systemic infection, and the latency period may be too 
long to suspect a causal relationship with the administration of drugs. 
The presence of the two criteria, as given by Bocquet et al., has high 
sensitivity (>95%) to diagnose DRESS. Proposed mechanism for 
lamotrigine causing DRESS includes hypersensitivity reaction to an 
aromatic ring containing antiepileptic drugs via immune activation. 
Other proposed mechanisms include formation of antibody and T-cell 
immune effectors. It is also said that levels of epoxide hydroxylase 
enzyme in the liver are found to be very low in patients who develop 
DRESS, and this leads to decreased elimination of toxic arene oxide 
metabolite of lamotrigine [3].
In our patient, there was elevated liver enzymes and eosinophilia with 
a fever which satisfied the criteria to diagnose DRESS. It was similar 
to the previous cases published in literature where it occurred after 
3 weeks of starting lamotrigine and resolved on stopping the drug. All 
other drugs causing DRESS were ruled, and other skin disorders were 
also ruled out. Causality assessment was done using Naranjo’s scale [4], 
and a probable causal relationship was ascribed. Adverse drug reaction 
was found to be moderately severe and not preventable as per Hartwig’s 
severity [5] and Thornton’s preventability scale [6].
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Case Report
Table 1: Laboratory investigations after lamotrigine therapy
Test done 28‑12‑2016 31‑12‑2015
ALT (IU/L) 42 115
ALP (U/L) 115 209
AST (IU/L) 52 73
ESR (mm/hr) 22 6
Eosinophil (%) 8 13
ALT: Alanine transaminase, ALP: Alkaline phosphatase, AST: Aspartate 
aminotransferase, ESR: Erythrocyte sedimentation rate
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CONCLUSION
This case highlights the need for early diagnosis and treatment of such a 
rare and life-threatening event because early detection of the condition 
leads to early recovery of the patient. Further re-exposure of the drug 
should be avoided.
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